Ruth R. Wexler
Bristol-Myers Squibb (Germany)(DE)Bristol-Myers Squibb (United States)(US)Bristol-Myers Squibb (Sweden)(SE)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Receptor Mechanisms and Signaling, Atrial Fibrillation Management and Outcomes, Chemical Synthesis and Analysis
Most-Cited Works
- → Angiotensin II receptors and angiotensin II receptor antagonists.(1993)1,857 cited
- → Identification of angiotensin II receptor subtypes(1989)822 cited
- → MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products(1998)404 cited
- → Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa(2007)391 cited
- → Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.(1990)330 cited
- → Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.